Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Multi-arm Trial of Ruxolitinib (RUX) and Fostamatinib (FOS) for COVID-19 Pneumonia

NCT04581954 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT04581954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04581954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Multi-arm Trial of Ruxolitinib (RUX) and Fostamatinib (FOS) for COVID-19 Pneumonia
Lead sponsor
Imperial College London
Phase
Phase 1/2
Overall status
Completed
Start date
October 2, 2020
Completion date
September 2, 2023
Enrollment
185 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus, covid19, pneumonia